McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. With more than 1,100 lawyers across several office locations worldwide, our team works seamlessly across practices, industries and geographies to deliver highly effective solutions that propel success.
This issue of McDermott's Healthcare Regulatory Check-Up highlights regulatory activity for October 2024. We discuss several enforcement actions pertaining to healthcare fraud, including alleged...
United StatesFood, Drugs, Healthcare, Life Sciences
This issue of McDermott's Healthcare Regulatory
Check-Up highlights regulatory activity for October 2024. We
discuss several enforcement actions pertaining to healthcare fraud,
including alleged violations under the False Claims Act (FCA) and
the federal Anti-Kickback Statute (AKS). We also review other
regulatory updates in the healthcare field, including notable
updates from the Centers for Medicare & Medicaid Services
(CMS).
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
